A structured methodology review showed analyses of functional outcomes are frequently limited to “survivors only” in trials enrolling patients at high risk of death
Elizabeth Colantuoni, Ximin Li, Mohamed D. Hashem, Timothy D. Girard, Daniel O. Scharfstein, Dale M. Needham
Topics & Concepts
MedicineRandomized controlled trialMEDLINEResearch designRelative riskPhysical therapyInternal medicineFamily medicineConfidence intervalPolitical scienceSociologyLawSocial scienceSepsis Diagnosis and TreatmentLong-Term Effects of COVID-19COVID-19 and healthcare impacts